Direct medical costs of diabetes mellitus in the year of mortality and year preceding the year of mortality.

This analysis provides new evidence on incorporating additional direct medical costs in the mortality year, and refining the structure of total cost estimates for use in costing and cost-effectiveness analyses of interventions for DM.